EGFR and non-small cell lung carcinoma: Finally, a less common but well documented mechanism of acquired resistance to EGFR-TKIs is histological transformation from NSCLC to SCLC or epithelial–mesenchymal transition (EMT), which has been reported in up to 3% of EGFR-TKI resistant patients (61).